Ricci, LivianaMackie, JoannaDonachie, Gillian E.Chapuis, Ambre FloraMezerova, KristynaLenardon, MeganBrown, AlistairDuncan, SylviaWalker, Alan2022-09-272022-09-272022-10Ricci, L, Mackie, J, Donachie, G E, Chapuis, A F, Mezerova, K, Lenardon, M, Brown, A, Duncan, S & Walker, A 2022, 'Human gut bifidobacteria inhibit the growth of the opportunistic fungal pathogen Candida albicans', FEMS Microbiology Ecology, vol. 98, no. 10, fiac095. https://doi.org/10.1093/femsec/fiac0951574-6941ORCID: /0000-0002-4903-0978/work/119826022ORCID: /0000-0001-5099-8495/work/119826226https://hdl.handle.net/2164/19231Open Access via the OUP Agreement Funding: Initial studies were funded from a Wellcome Institutional Strategic Support Fund (ISSF) Seed Corn Award [105625/Z/14/Z]. Thereafter, the research was funded by the Scottish Government’s Rural and Environment Science and Analytical Services (RESAS) division. AJPB was supported by programme grants from the UK Medical Research Council (MR/M026663/1; MR/M026663/2) and by the Medical Research Council Centre for Medical Mycology (MR/N006364/1; MR/N006364/2). Acknowledgements: We thank Dr Donna M. MacCallum for critical reading of the manuscript, the Centre for Genome-Enabled Biology and Medicine at the University of Aberdeen for carrying out the 16S rRNA gene sequencing, and Donna Henderson for GC analysis of bacterial fermentation acids. The authors also acknowledge the support of the Maxwell computer cluster funded by the University of Aberdeen.153176554engSDG 3 - Good Health and Well-beingHuman gut microbiotabifidobacteriacolonisation resistanceCandida albicansshort chain fatty acidslactatepHR MedicineWellcome Trust105625/Z/14/ZMedical Research Council (MRC)MR/M026663/1MR/M026663/2MR/N006364/1MR/N006364/2Supplementary DataRJournal article10.1093/femsec/fiac0959810